MX2011011842A - Composiciones, metodos y equipos para acidos grasos poliinsaturados a partir de microalgas. - Google Patents

Composiciones, metodos y equipos para acidos grasos poliinsaturados a partir de microalgas.

Info

Publication number
MX2011011842A
MX2011011842A MX2011011842A MX2011011842A MX2011011842A MX 2011011842 A MX2011011842 A MX 2011011842A MX 2011011842 A MX2011011842 A MX 2011011842A MX 2011011842 A MX2011011842 A MX 2011011842A MX 2011011842 A MX2011011842 A MX 2011011842A
Authority
MX
Mexico
Prior art keywords
kits
methods
microalgae
fatty acids
compositions
Prior art date
Application number
MX2011011842A
Other languages
English (en)
Inventor
Floyd Chilton
Fan Lu
Original Assignee
Wake Forest University School Of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wake Forest University School Of Medicine filed Critical Wake Forest University School Of Medicine
Publication of MX2011011842A publication Critical patent/MX2011011842A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409—Fatty acids
    • C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/04—Rhodophycota or rhodophyta (red algae), e.g. Porphyra
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/48—Separation; Purification; Stabilisation; Use of additives by liquid-liquid treatment
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00—Production of fats or fatty oils from raw materials
    • C11B1/10—Production of fats or fatty oils from raw materials by extracting
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409—Fatty acids
    • C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
    • C12P7/6432—Eicosapentaenoic acids [EPA]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409—Fatty acids
    • C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
    • C12P7/6434—Docosahexenoic acids [DHA]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81—Aquaculture, e.g. of fish
    • Y02A40/818—Alternative feeds for fish, e.g. in aquacultures

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Food Science & Technology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Animal Husbandry (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)

Abstract

La presente invención proporciona composiciones, métodos y equipos que comprenden Ácidos Grasos Poli Insaturados, AGPI (PUFAs = Polyunsaturated Fatty Acids) producidos por microalgas, en particular, ácidos grasos omega-3 y/u omega-6 producidos por miembros del género Rhodomonas, en particular Rhodomonas salina. La invención también proporciona composiciones, métodos y equipos que comprenden los AGPI (PUFAs) para el tratamiento profiláctico y/o terapéutico de una enfermedad o condición, en particular una enfermedad o condición cardiovascular y/o inflamatoria.
MX2011011842A 2009-05-06 2010-05-04 Composiciones, metodos y equipos para acidos grasos poliinsaturados a partir de microalgas. MX2011011842A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/436,542 US8343753B2 (en) 2007-11-01 2009-05-06 Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
PCT/US2010/033569 WO2010129565A2 (en) 2009-05-06 2010-05-04 Compositions, methods, and kits for polyunsaturated fatty acids from microalgae

Publications (1)

Publication Number Publication Date
MX2011011842A true MX2011011842A (es) 2012-02-28

Family

ID=43050826

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011011842A MX2011011842A (es) 2009-05-06 2010-05-04 Composiciones, metodos y equipos para acidos grasos poliinsaturados a partir de microalgas.

Country Status (8)

Country Link
US (2) US8343753B2 (es)
EP (1) EP2427564A2 (es)
JP (1) JP2012525846A (es)
CN (1) CN102597255A (es)
AU (1) AU2010246087A1 (es)
CA (1) CA2761495A1 (es)
MX (1) MX2011011842A (es)
WO (1) WO2010129565A2 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8207363B2 (en) 2009-03-19 2012-06-26 Martek Biosciences Corporation Thraustochytrids, fatty acid compositions, and methods of making and uses thereof
KR20120133381A (ko) 2010-01-19 2012-12-10 디에스엠 아이피 어셋츠 비.브이. 에이코사펜타엔산 생산 미생물, 지방산 조성물 및 이의 제조방법 및 용도
WO2011143229A2 (en) * 2010-05-10 2011-11-17 J3H, Inc. Lipid compositions and structured lipids containing phospholipids, oral formulations containing the same and methods of making the same
NZ588781A (en) * 2010-10-22 2013-08-30 Photonz Corp Ltd Method of provision of silicate to culture media
KR101167865B1 (ko) 2010-11-11 2012-07-23 대구대학교 산학협력단 깻잎녹병 곰팡이 순수 배양용 인공배지 조성물
US20130245119A1 (en) * 2010-11-19 2013-09-19 Keio University Therapeutic or prophylactic agent for corneal epithelium disorders and/or conjunctival epithelium disorders
WO2012128396A1 (en) * 2011-03-24 2012-09-27 Kao Corporation Method of producing lauric acid-containing oil or fat and lauric acid or esters thereof
ES2537982T3 (es) * 2011-04-01 2015-06-16 Neste Oil Oyj Método para la recuperación de un componente celular específico a partir de un microorganismo
US20140099684A1 (en) * 2011-05-26 2014-04-10 Council Of Scientific & Industrial Research Engine worthy fatty acid methyl ester (biodiesel) from naturally occuring marine microalgal mats and marine microalgae cultured in open salt pans together with value addition of co-products
EP2734197A4 (en) 2011-07-21 2014-12-17 Dsm Ip Assets Bv FATTY ACID COMPOSITIONS
FR2985187B1 (fr) * 2012-01-04 2015-11-20 Lvmh Rech Extrait de graines de kniphofia uvaria, composition cosmetique ou dermatologique en contenant, et ses utilisations.
US9243207B2 (en) 2012-02-29 2016-01-26 Exxonmobil Research And Engineering Company Solvent extraction of products from algae
CN103907766A (zh) * 2012-12-28 2014-07-09 新奥科技发展有限公司 一种禽类饲料添加剂、包含其的饲料及其应用
EP2826384A1 (de) 2013-07-16 2015-01-21 Evonik Industries AG Verfahren zur Trocknung von Biomasse
CN107072182B (zh) * 2014-07-17 2021-11-09 康奈尔大学 用脱脂微藻动物饲料对家禽产品的ω-3脂肪酸富集
AU2015301478A1 (en) * 2014-08-14 2017-03-09 Change Cola, Inc. Carbonated drink comprising omega, vitamins and minerals
BR112017006838B1 (pt) 2014-10-02 2021-07-06 Evonik Operations Gmbh Processo para produzir um alimento para animais compreendendo biomassa contendo pufa, alimento para animais e método para criar animais
BR112017006834B1 (pt) 2014-10-02 2022-04-26 Evonik Operations Gmbh Processo para a preparação de um alimento para animais compreendendo pufas, produto extrudado de alimento para animais e método de criação de animais
US11464244B2 (en) 2014-10-02 2022-10-11 Evonik Operations Gmbh Feedstuff of high abrasion resistance and good stability in water, containing PUFAs
WO2016050556A1 (de) 2014-10-02 2016-04-07 Evonik Degussa Gmbh Verfahren zur anzucht von tieren
CN107614676B (zh) * 2015-03-04 2021-04-16 湖北工业大学 应用颗石类微藻卡氏侧金藻生产聚不饱和脂肪酸的方法
CN106148194B (zh) * 2015-04-17 2019-10-08 财团法人食品工业发展研究所 微藻和其用途
US10183044B2 (en) * 2015-05-15 2019-01-22 P Tech, Llc Systems and methods for thrombosis prevention
FR3052337B1 (fr) * 2016-06-08 2018-06-29 Immunrise Biocontrol France Extrait cellulaire d'une ou plusieurs micro-algues du genre amphidinium pour son activite fongicide et/ou bactericide sur les champignons, les oomycetes et/ou bacteries pathogenes des plantes et semences de culture.
CN106260630A (zh) * 2016-08-08 2017-01-04 新奥科技发展有限公司 一种提高猪肉脂肪中不饱合脂肪酸含量的猪饲料
CN106916751B (zh) * 2017-03-12 2020-09-25 江南大学 一种混合培养盐生红胞藻的方法
CN106636264B (zh) * 2017-03-12 2020-11-03 江南大学 一种利用盐生红胞藻产藻红蛋白和多不饱和脂肪酸的方法
KR101818887B1 (ko) * 2017-07-18 2018-01-16 서울대학교산학협력단 다중불포화지방산 생산용 미세조류 배양 배지 조성물 및 방법
US11412968B2 (en) 2017-09-12 2022-08-16 Get Together, Inc System and method for a digital therapeutic delivery of generalized clinician tips (GCT)
CN109504472A (zh) * 2018-11-02 2019-03-22 石首市博锐德生物科技有限公司 微藻基生物质炼制方法以及实施其的***

Family Cites Families (307)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4154863A (en) * 1977-01-28 1979-05-15 Rich Products Corporation Intermediate moisture, ready-to-use, frozen foods
US4444755A (en) * 1978-01-23 1984-04-24 Efamol Limited Treatment for skin disorders
EP0004770B1 (en) * 1978-04-11 1984-06-13 Efamol Limited Pharmaceutical and dietary composition comprising gamma-linolenic acids
US4386072A (en) * 1981-06-26 1983-05-31 Horrobin David F Treatment of disorders of inflammation and immunity and disorders associated with smooth muscle spasm and compositions therefor
EP0179959A1 (en) * 1982-04-20 1986-05-07 Merck Frosst Canada Inc. Conjugates of leukotrienes with proteins
IE54795B1 (en) * 1982-04-29 1990-02-14 Efamol Ltd Pharmaceutical composition
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
US4560514A (en) * 1984-05-04 1985-12-24 Bengt Samuelsson Inflammatory lipoxin A and anti-anflammatory lipoxin B compounds
US4576758A (en) * 1984-06-01 1986-03-18 The Upjohn Company Anti-inflammatory lipoxin B analogs
GB8425006D0 (en) * 1984-10-03 1984-11-07 Efamol Ltd Composition of copper/fatty acids
GB8507058D0 (en) * 1985-03-19 1985-04-24 Efamol Ltd Pharmaceutical & dietary compositions
GB8524276D0 (en) * 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
US5073561A (en) * 1987-03-31 1991-12-17 Warner-Lambert Company Methods of treating depression and psychoses
US4918104A (en) * 1987-06-16 1990-04-17 Weiss Howard S Method and composition for increasing the concentration of omega-3 polyunsaturated fatty acids in poultry and poultry eggs and poultry and eggs resulting therefrom
FR2618332B1 (fr) * 1987-07-23 1990-04-27 Synthelabo Emulsion lipidique destinee a la nutrition parenterale ou enterale
US5069903A (en) * 1987-12-16 1991-12-03 Stitt Paul A Therapeutic and nutritive flax seed composition and methods employing the same
EP0561766B1 (en) * 1988-01-14 1995-11-02 FRITHZ, Anders Use of essential fatty acids for the preparation of a drug for the treatment of eczema
GB8813766D0 (en) * 1988-06-10 1988-07-13 Efamol Holdings Essential fatty acid compositions
GB8819110D0 (en) * 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
US5130242A (en) * 1988-09-07 1992-07-14 Phycotech, Inc. Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids
US5340742A (en) * 1988-09-07 1994-08-23 Omegatech Inc. Process for growing thraustochytrium and schizochytrium using non-chloride salts to produce a microfloral biomass having omega-3-highly unsaturated fatty acids
US5116871A (en) * 1988-09-13 1992-05-26 Efamol Holdings Plc Fatty acid therapy and compositions for the treatment of myalgic encephalomyelitis
US5059622A (en) * 1989-08-29 1991-10-22 Biosyn, Inc. Method for reducing blood pressure levels in hypertensive persons
US6140304A (en) * 1988-09-28 2000-10-31 Eicotech Corporation Method of and nutritional and pharmaceutical compositions for reduction of hyperinsulinemia
CH676909A5 (es) * 1988-12-23 1991-03-28 Nestle Sa
ES2102984T3 (es) * 1989-06-14 1997-08-16 Martek Corp Medios para el crecimiento de celulas y procedimiento para preparar los mismos.
GB8918294D0 (en) * 1989-08-10 1989-09-20 Efamol Holdings Pharmaceutical compositions
FR2652588A1 (fr) * 1989-10-04 1991-04-05 Medgenix Group Sa Procede de production d'un melange de glycerides enrichis en acides gras.
GB9001121D0 (en) * 1990-01-18 1990-03-21 Efamol Holdings Efa compositions and therapy
US5407957A (en) * 1990-02-13 1995-04-18 Martek Corporation Production of docosahexaenoic acid by dinoflagellates
US5244921A (en) * 1990-03-21 1993-09-14 Martek Corporation Eicosapentaenoic acids and methods for their production
JP2611852B2 (ja) * 1990-04-17 1997-05-21 富士写真フイルム株式会社 ハロゲン化銀写真感光材料
DK0457950T3 (da) * 1990-05-23 1994-03-07 Nestle Sa Anvendelse af stearidonsyre til behandling af inflammatorisk betingede sygdomme
GB9012651D0 (en) * 1990-06-06 1990-07-25 Efamol Holdings Essential fatty acid treatment
US5472841A (en) * 1990-06-11 1995-12-05 Nexstar Pharmaceuticals, Inc. Methods for identifying nucleic acid ligands of human neutrophil elastase
ZA92452B (en) * 1991-01-24 1992-10-28 Martek Corp Microbial oil mixtures and uses thereof
JP2696613B2 (ja) * 1991-03-08 1998-01-14 美穂 田中 養魚用飼料とその製造法
JPH04121282U (ja) * 1991-04-15 1992-10-29 日本メジフイジツクス株式会社 試薬供給器
SE9101642D0 (sv) * 1991-05-30 1991-05-30 Kabi Pharmacia Ab Phospholipids
GB9111900D0 (en) * 1991-06-03 1991-07-24 Efamol Holdings Fatty acid compositions
GB9112052D0 (en) * 1991-06-05 1991-07-24 Efamol Holdings Fatty acid treatment
DE4133694C2 (de) * 1991-10-11 1993-10-07 Fresenius Ag Verwendung einer Emulsion mit mehrfach ungesättigten Fettsären zur i.v.-Verabreichung zur Behandlung von Hauterkrankungen
FR2686619B1 (fr) * 1992-01-28 1995-07-13 Commissariat Energie Atomique Procede de production selective de lipides poly-insatures a partir d'une culture de micro-algues du type porphyridium et cuve utilisee dans ce procede.
SE9200541D0 (sv) * 1992-02-24 1992-02-24 Kabi Pharmacia Ab New usee of omega-3-fatty acids
US5223285A (en) * 1992-03-31 1993-06-29 Abbott Laboratories Nutritional product for pulmonary patients
US5674901A (en) * 1995-06-01 1997-10-07 Wisconsin Alumni Research Foundation Methods of treating animals to maintain or increase CD-4 and CD-8 cell populations
US5430066A (en) * 1992-04-29 1995-07-04 Wisconsin Alumni Research Foundation Methods for preventing weight loss, reduction in weight gain, and anorexia due to immune stimulation
US5683898A (en) * 1992-05-15 1997-11-04 Sagami Chemical Research Center Gene coding for eicosapentaenoic acid synthesizing enzymes and process for production of eicosapentaenoic acid
US5422371A (en) * 1992-05-27 1995-06-06 Arch Development Corp. Methods and compositions for inhibiting 5α-reductase activity
GB9211229D0 (en) * 1992-05-27 1992-07-08 Efamol Holdings Fatty acid treatment
GB9217780D0 (en) * 1992-08-21 1992-10-07 Efamol Holdings Fatty acid treatment
US5888541A (en) * 1992-08-21 1999-03-30 Scotia Holdings Plc Fatty acid treatment
US5516801A (en) * 1992-08-21 1996-05-14 Scotia Holdings Plc Fatty acid treatment for ectopic calcium deposition
GB9218064D0 (en) * 1992-08-25 1992-10-14 Efamol Holdings Method for the safe intravenous administration of fatty acids
JPH06141886A (ja) * 1992-11-06 1994-05-24 Nippon Paper Ind Co Ltd 高温耐性及び消化吸収性の改善されたファフィア・ロドチーマによるアスタキサンチンの生産方法
DE4238869C2 (de) 1992-11-18 1994-09-08 Wogepharm Gmbh Mittel zur Behandlung des atopischen Ekzems und anderer entzündlicher Hautkrankheiten
GB9224809D0 (en) * 1992-11-26 1993-01-13 Scotia Holdings Plc Schizophrenia
GB9301446D0 (en) * 1993-01-26 1993-03-17 Scotia Holdings Plc Internal radiation damage
AU673700B2 (en) * 1993-01-27 1996-11-21 Scotia Holdings Plc Triglycerides
CA2119000A1 (en) * 1993-03-19 1994-09-20 David Frederick Horrobin Formulation for use in smokers
US20050027004A1 (en) 1993-06-09 2005-02-03 Martek Biosciences Corporation Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions
US5411988A (en) * 1993-10-27 1995-05-02 Bockow; Barry I. Compositions and methods for inhibiting inflammation and adhesion formation
FR2722410B1 (fr) * 1994-07-15 1996-10-04 Grinda Jean Robert Procede de stabilisation des acides gras poly-insatures et utilisation de ces produits stabilises entherapeutique
US5660842A (en) * 1994-10-04 1997-08-26 Bristol-Myers Squibb Company Inhibition of helicobacter
EP0711503A3 (en) 1994-11-14 1997-11-26 Scotia Holdings Plc Milk fortified with GLA and/or DGLA
GB9423625D0 (en) 1994-11-23 1995-01-11 Scotia Holdings Plc Fortified fruit juice
GB9509764D0 (en) * 1995-05-15 1995-07-05 Tillotts Pharma Ag Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
GB9510636D0 (en) * 1995-05-25 1995-07-19 Scotia Holdings Plc Fatty acid treatment
US5948451A (en) 1995-07-04 1999-09-07 Suntory Limited Method of modifying the balance of omega unsaturated fatty acids using a dioxabicyclo octane derivative
GB9519661D0 (en) * 1995-09-27 1995-11-29 Scotia Holdings Plc Fatty acid treatment
US6255505B1 (en) 1996-03-28 2001-07-03 Gist-Brocades, B.V. Microbial polyunsaturated fatty acid containing oil from pasteurised biomass
JP2000509079A (ja) 1996-04-11 2000-07-18 ロダース・クロックラーン・ビー・ブイ 自由流動性脂肪組成物
US6340485B1 (en) * 1996-06-03 2002-01-22 Croda International Plc Compositions and uses thereof
GB9617847D0 (en) * 1996-08-27 1996-10-09 Scotia Holdings Plc Fatty acid treatment
GB9618420D0 (en) 1996-09-04 1996-10-16 Scotia Holdings Plc Fatty acid treatment
JP4633204B2 (ja) * 1996-10-11 2011-02-16 サントリーホールディングス株式会社 アラキドン酸含有食用油脂およびそれを含有する食品
JP4151853B2 (ja) * 1996-10-11 2008-09-17 スカリスタ リミテッド エイコサペンタエン酸および／またはステアリドン酸を含む治療用薬剤
US8828432B2 (en) 1996-10-28 2014-09-09 General Mills, Inc. Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles
US5843919A (en) * 1996-11-25 1998-12-01 Burger; John A. Composition and method for the treatment of arthritis
US5855917A (en) * 1996-12-04 1999-01-05 Wisconsin Alumni Research Foundation Method for controlling body fat and/or body weight in animals and pharmaceutical compositions for use therein comprising 20-carbon conjugated unsaturated fatty acids
US6344482B1 (en) * 1997-04-23 2002-02-05 Andrew L. Stoll Omega-3 fatty acids in the treatment of bipolar disorder
US5993221A (en) * 1997-05-01 1999-11-30 Beth Israel Deaconess Medical Center, Inc. Dietary formulation comprising arachidonic acid and methods of use
GB9715444D0 (en) * 1997-07-22 1997-09-24 Scotia Holdings Plc Therapeutic and dietary compositions
EP0996740B1 (en) 1997-08-01 2005-09-21 Martek Biosciences Corporation Dha-containing nutritional compositions and methods for their production
NZ502677A (en) * 1997-08-14 2002-08-28 Omegatech Inc A method for increasing incorporation efficiency of omega-3 highly unsaturated fatty acid in poultry meat
DE19750422C1 (de) 1997-11-14 1998-11-26 Henkel Kgaa Verwendung von ausgewählten Phytostenolestern zur Herstellung von hypocholesterinämischen Mitteln
US20030152983A1 (en) 1997-12-23 2003-08-14 University Of Bristol Desaturase
CN1289091C (zh) 1998-02-11 2006-12-13 Rtp药品公司 治疗炎症的药物组合物和相关用途
US7138431B1 (en) 1998-02-23 2006-11-21 Wake Forest University Dietary control of arachidonic acid metabolism
US6107334A (en) * 1998-02-23 2000-08-22 Wake Forest University Dietary control of arachidonic acid metabolism
PE20000601A1 (es) 1998-03-23 2000-07-25 Gen Mills Inc Encapsulado de componentes en productos comestibles
IT1304406B1 (it) * 1998-10-21 2001-03-19 Danital Italia S R L Preparazione per la veicolazione di principi attivi basata su acidigrassi polinsaturi del gruppo omega 3.
ATE306194T1 (de) * 1999-02-12 2005-10-15 Nestle Sa Stabilisierte fettmischung, methode zu ihrer herstellung und lebensmittel, welches das fett enthält
US6596766B1 (en) * 1999-03-04 2003-07-22 Suntory Limited Utilization of material containing docosapentaenoic acid
US20050037065A1 (en) 1999-05-27 2005-02-17 Drugtech Corporation Nutritional formulations
US6258846B1 (en) * 1999-06-01 2001-07-10 Drugtech Corporation Nutritional supplements
GB9916536D0 (en) 1999-07-14 1999-09-15 Scarista Limited Nutritional or pharmaceutical compositions
JP4669095B2 (ja) * 1999-07-19 2011-04-13 太陽化学株式会社 ペットの問題行動抑制組成物
US7157254B1 (en) 1999-08-13 2007-01-02 Suntory Limited Microorganism secreting out lipid and process for producing the lipid and lipid balls having the lipid encapsulating therein by using the mircroorganism
CA2382262C (en) 1999-08-30 2004-12-07 Ocean Nutrition Canada Ltd. A nutritional supplement for lowering serum triglyceride and cholesterol levels
US6340705B1 (en) * 1999-09-10 2002-01-22 Monsanto Technology, Llc Use of α-linolenic acid metabolites for treatment or prevention of cancer
EP1220669A4 (en) 1999-10-13 2004-12-08 Marco A Chacon THERAPEUTIC MEASURE TO IMPROVE THE EFFECT OF A CALORY RESTRICTION
US6737078B1 (en) 1999-11-24 2004-05-18 The Iams Company Process for enhancing canine and feline reproductive performance
US20010047036A1 (en) 1999-12-17 2001-11-29 Vanderhoof Jon A. Composition for improving the proliferative response during adaptation of the gastrointestinal tract and use in short bowel syndrome
US20020146400A1 (en) 2000-01-07 2002-10-10 Cincotta Anthony H. Composition for reducing plasma triglycerides, platelet aggregation, and oxidative capacity
ATE485385T1 (de) 2000-01-19 2010-11-15 Martek Biosciences Corp Lösungsmittelfreies extraktionsverfahren
US6277417B1 (en) * 2000-04-07 2001-08-21 Triarco Industries, Inc. Method of inhibiting 5α-reductase with astaxanthin
US7208180B2 (en) 2000-05-08 2007-04-24 N.V. Nutricia Method and preparation for the preventing and/or treating vascular disorders and secondary disorders associated therewith
US7226916B1 (en) 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
WO2002000028A1 (en) 2000-06-26 2002-01-03 Martek Biosciences Boulder Corporation Improved methods of incorporating polyunsaturated fatty acids in milk
US6407705B1 (en) * 2000-06-27 2002-06-18 Mohamed Said Sanad Compact broadband high efficiency microstrip antenna for wireless modems
GB0016045D0 (en) * 2000-06-29 2000-08-23 Laxdale Limited Therapeutic combinations of fatty acids
EP1178118A1 (en) * 2000-08-02 2002-02-06 Dsm N.V. Isolation of microbial oils
JP2002047176A (ja) 2000-08-04 2002-02-12 Idemitsu Technofine Co Ltd ＩｇＥ産生抑制剤
ATE265218T1 (de) 2000-08-10 2004-05-15 Ocean Nutrition Canada Ltd Chlorella zubereitungen mit immunmodulatorischen eigenschaften
US6667064B2 (en) 2000-08-30 2003-12-23 Pilot Therapeutics, Inc. Composition and method for treatment of hypertriglyceridemia
US20040037892A1 (en) 2001-11-19 2004-02-26 Adrianne Bendich Dietary composition containing conjugated linoleic acid and calcium for improved health
CN1218035C (zh) * 2000-12-11 2005-09-07 姜悦 利用海洋微藻异养培养生产长链多不饱和脂肪酸
JP2002209516A (ja) 2001-01-19 2002-07-30 Nisshin Oil Mills Ltd:The 食用油脂組成物
ITMI20010129A1 (it) 2001-01-25 2002-07-25 Pharmacia & Upjohn Spa Acidi grassi essenziali nella terapia di insufficienza cardiaca e scompenso cardiaco
US6277435B1 (en) * 2001-02-26 2001-08-21 Martine Lacombe Kosher-meat based pet food products
DE60138602D1 (de) 2001-03-09 2009-06-18 Nestle Sa Öl, das langkettige, mehrfach ungesättigte Fettsäuren aus Biomassen enthält, Verfahren zur Herstellung, Lebensmittel, Nahrungsmittelzusammensetzung, kosmetische oder pharmazeutische Zusammensetzung, die dieses enthält
US7001610B2 (en) 2001-04-23 2006-02-21 Omeganutrel Inc. Food supplement and use thereof for elevating levels of essential fatty acids in livestock and products therefrom
GB0111282D0 (en) 2001-05-09 2001-06-27 Laxdale Ltd Potentiation of therapeutic effects of fatty acids
EP2275101A1 (en) 2001-05-14 2011-01-19 Martek Biosciences Corporation Polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes, and its uses
MX281182B (es) 2001-05-14 2010-11-22 Martek Biosciences Boulder Corp Produccion y uso de una fraccion rica en lipidos polares, que contienen acidos grasos altamente insaturados omega-3 y/u omega-6, procedentes de microbios, de semillas de plantas y de organismos marinos geneticamente modificados.
GB0113348D0 (en) 2001-06-01 2001-07-25 Mars Uk Ltd Skin diet
JP2003048831A (ja) 2001-08-02 2003-02-21 Suntory Ltd 脳機能の低下に起因する症状あるいは疾患の予防又は改善作用を有する組成物
US20030032674A1 (en) 2001-08-13 2003-02-13 Hwang Daniel H. Use of unsaturated fatty acids to treat severe inflammatory diseases
US20050101563A1 (en) 2001-08-14 2005-05-12 Pharmacia Corporation Method and compositions for the treatment and prevention of pain and inflammation
WO2003017945A2 (en) 2001-08-24 2003-03-06 Martek Biosciences Boulder Corporation Products containing highly unsaturated fatty acids for use by women and their children during stages of preconception, pregnancy and lactation/post-partum
JP4116844B2 (ja) 2001-09-13 2008-07-09 花王株式会社 油脂組成物
US6656969B2 (en) 2001-09-20 2003-12-02 Mayo Foundation For Medical Education And Research Methods and compositions for inhibiting the proliferation of prostate cancer cells
ITMI20012384A1 (it) 2001-11-12 2003-05-12 Quatex Nv Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori
NL1019368C2 (nl) 2001-11-14 2003-05-20 Nutricia Nv Preparaat voor het verbeteren van receptorwerking.
US20030144219A1 (en) 2001-11-15 2003-07-31 Phinney Stephen Dodge Formulations and methods for treatment or amelioration of inflammatory conditions
US8729124B2 (en) 2002-03-05 2014-05-20 Pronova Biopharma Norge As Use of EPA and DHA in secondary prevention
CN101072509A (zh) 2002-03-08 2007-11-14 孟山都技术有限公司 炎症的治疗和预防
US20030175403A1 (en) 2002-03-14 2003-09-18 Gurin Michael H. Potentiated bioactive additives and method of use
AU2003220137A1 (en) 2002-03-19 2003-10-08 David J. Kyle Microalgal feeds containing arachidonic acid and their production and use
US20030203004A1 (en) 2002-04-24 2003-10-30 Kelm Gary Robert Compositions comprising short and long chain fatty acids and methods of their use for the management of body weight
US20030215465A1 (en) 2002-04-25 2003-11-20 Lc Usa Llc Use of conjugated acid derivatives
EP2921155B1 (en) 2002-05-03 2020-01-08 DSM IP Assets B.V. Methods for producing high-quality lipids by enzymatic liberation from biomass
FR2839887A1 (fr) 2002-05-22 2003-11-28 Synergia Nouvelles compositions nutraceutiques et pharmaceutiques et leurs utilisations
US20060165735A1 (en) 2002-06-18 2006-07-27 Abril Jesus R Stable emulsions of oils in aqueous solutions and methods for producing same
US20040001874A1 (en) 2002-06-24 2004-01-01 Vital Living, Inc. Safe and effective nutritional supplement formulations and associated regimens adapted to prevent and/or treat targeted diseases or medical or health conditions, and related methods
EP1517667A2 (en) 2002-07-02 2005-03-30 Galileo Pharmaceuticals, Inc. Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects
US20040132819A1 (en) 2002-08-06 2004-07-08 Nancy Auestad Appetite control method
US7410663B2 (en) 2002-08-07 2008-08-12 Kao Corporation Oil or fat composition
EP1388295A1 (en) 2002-08-07 2004-02-11 Nestec S.A. Cereal based food product comprising DHA
DE60228707D1 (de) 2002-09-04 2008-10-16 Nestec Sa Verfahren zur Herstellung von einem Öl, das langkettige, mehrfach ungesättigte Fettsäuren aus Biomassen enthält, Lebensmittel, Nahrungsmittelzusammensetzung, kosmetische oder pharmazeutische Zusammensetzung, die dieses Ölenthält
GB0221480D0 (en) 2002-09-16 2002-10-23 Laxdale Ltd Treatment of anorexia nervosa (AN) and bulimia
JP4771697B2 (ja) 2002-09-24 2011-09-14 サントリーホールディングス株式会社 認知能力の正常応答の低下予防、改善又は向上作用を有する組成物
WO2004028470A2 (en) 2002-09-27 2004-04-08 Martek Biosciences Corporation Prophylactic docosahexaenoic acid therapy for patients with subclinical inflammation
WO2004028469A2 (en) 2002-09-27 2004-04-08 Martek Biosciences Corporation Docohexaenoic acid for improved glycemic control
US7445807B2 (en) 2002-10-15 2008-11-04 Western Holdings, Llc Agglomerated granular protein-rich nutritional supplement
ZA200503463B (en) 2002-10-31 2010-04-28 Fasgen Llc The Johns Hopkins U A method for inhibiting cancer development by fatty acid synthase inhibitors
DE10254584A1 (de) 2002-11-22 2004-06-09 HORST HEIRLER PROJEKTE für Ernährung, Medizin, Ökologie Verwendung von mittelkettigen Triglyceriden (MCT) zur ernährungsphysiologischen Optimierung des Fettsäurenspektrums in einem diätetischen Lebensmittel für Diabetiker
ES2209658B1 (es) 2002-12-05 2005-10-01 Proyecto Empresarial Brudy, S.L. Utilizacion del acido docosahexaenoico como principio activo para el tratamiento de la lipodistrofia.
DE10261067A1 (de) 2002-12-24 2004-08-05 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Cholesterinsenkendes Mittel, enthaltend eine n-3-Fettsäure
JP4570563B2 (ja) 2003-02-21 2010-10-27 持田製薬株式会社 リバビリン／インターフェロン併用療法の副作用軽減剤
US20040235948A1 (en) 2003-03-05 2004-11-25 Solvay Pharmaceuticals Gmbh Treatment of diabetic patients with omega-3-fatty acids
US20060265766A1 (en) * 2003-03-19 2006-11-23 Advanced Bionutrition Corporation Fish and the production thereof
US20070184135A1 (en) 2003-03-26 2007-08-09 Palu Afa K Morinda citrifolia-based formulation 5-LOX and 15-LOX
WO2004084882A1 (en) 2003-03-27 2004-10-07 Suntory Limited Use of arachidonic acid for normalization of infradian rhythm
US20040191294A1 (en) 2003-03-27 2004-09-30 Ramaprasad Talahalli Ravichandra Health composition
DE10317109A1 (de) 2003-04-14 2004-11-11 Cognis Deutschland Gmbh & Co. Kg Zubereitungen zur oralen Aufnahme
US20040208939A1 (en) 2003-04-18 2004-10-21 Barry Sears Novel dietary compositions to reduce inflammation
CN102125538B (zh) 2003-05-27 2014-05-07 帝斯曼知识产权资产管理有限公司 新颖的营养药物性组合物及其用途
EP1634588A4 (en) 2003-05-28 2007-04-04 Eisai R&D Man Co Ltd COMPOSITIONS AND FOOD AND BEVERAGES WITH HIGHER FATTY ACID DERIVATIVE
DE10324548A1 (de) 2003-05-28 2004-12-16 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Diätisches Lebensmittel bei einer gewichtskontrollierenden bzw. gewichtsreduzierenden Ernährung
JP4870430B2 (ja) 2003-06-20 2012-02-08 持田製薬株式会社 下肢静脈瘤予防・治療用組成物
RU2346448C2 (ru) 2003-06-23 2009-02-20 Нестек С.А. Смесь для детей первых месяцев жизни или старше
US20050075398A1 (en) 2003-08-05 2005-04-07 Bazan Nicolas G. Neuroprotectin D1 protects against cellular apoptosis, stroke damage, alzheimer's disease and retinal diseases
US20050032757A1 (en) 2003-08-06 2005-02-10 Cho Suk H. Nutritional supplements
US20050032892A1 (en) 2003-08-07 2005-02-10 The Procter & Gamble Company Compositions, kits, and methods for treating gastrointestinal conditions
WO2005018630A1 (en) 2003-08-11 2005-03-03 Hill's Pet Nutrition, Inc. Omega-3 fatty acids for the treatment of canine ostheoarthritis
EP1656449B1 (en) * 2003-08-21 2009-05-06 Monsanto Technology LLC Fatty acid desaturases from primula
US20050202063A1 (en) 2003-08-26 2005-09-15 Ebn International Kft Food product
WO2005023021A1 (ja) 2003-09-02 2005-03-17 Bbk Bio Corporation ダイエット食品
US7759507B2 (en) 2003-09-05 2010-07-20 Abbott Laboratories Lipid system and methods of use
US7396672B2 (en) 2003-09-30 2008-07-08 Tin Yum Joseph Wong Method for the production of dinoflagellate cultures
WO2005034874A2 (en) 2003-10-08 2005-04-21 The Mclean Hospital Corporation Enhanced efficacy of omega-3 fatty acid therapy in the treatment of psychiatric disorders and other indications
JP4522075B2 (ja) 2003-10-29 2010-08-11 サントリーホールディングス株式会社 血管の老化に起因する症状あるいは疾患の予防又は改善作用を有する組成物
RU2376782C2 (ru) 2003-11-28 2009-12-27 Онбио Корпорейшн Масляная композиция и содержащие ее пищевые продукты, фармацевтическая композиция и пищевая добавка
SE0303513D0 (sv) 2003-12-19 2003-12-19 Pronova Biocare As Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof
KR20060127865A (ko) 2003-12-22 2006-12-13 와쿠나가 세이야쿠 가부시키 가이샤 유지 조성물
WO2005063231A2 (en) 2003-12-31 2005-07-14 Igennus Limited Formulation containing an eicosapentaenoic acid or an ester thereof and a triterpene or esther thereof
US20050154059A1 (en) 2004-01-13 2005-07-14 Cook Mark E. Method of treating type III hypersensitive reaction-related diseases and conditions by using conjugated linoleic acid
JP4721642B2 (ja) 2004-01-20 2011-07-13 サントリーホールディングス株式会社 肝障害を伴う肝臓疾患の予防又は改善剤
ITMI20040069A1 (it) 2004-01-21 2004-04-21 Tiberio Bruzzese Uso di composizioni di acidi grassi n-3 ad elevata concentrazione per il trattamento di disturbi del sistema nervoso centrale
US20060182820A1 (en) 2004-02-10 2006-08-17 Cargill, Incorporated Homogeneous Dispersions Containing Citrus Pulp and Applications Thereof
SG150563A1 (en) 2004-03-01 2009-03-30 Suntory Ltd Process for producing phospholipid containing long chain polyunsaturated fatty acid as constituent thereof and utilization of the same
US8114906B2 (en) 2004-04-16 2012-02-14 Abbott Products Gmbh Essential fatty acids in the treatment and/or inhibition of depression in patients with coronary heart or artery disease
ES2529572T3 (es) 2004-04-22 2015-02-23 Commonwealth Scientific And Industrial Research Organisation Síntesis de ácidos grasos poliinsaturados de cadena larga por células recombinantes
US20050266051A1 (en) 2004-05-27 2005-12-01 The Procter & Gamble Company Pet food compositions and methods
US20080044481A1 (en) 2004-05-27 2008-02-21 Mordechai Harel Microparticles for Oral Delivery
CA2568689A1 (en) 2004-06-04 2005-12-15 Fluxome Sciences A/S Metabolically engineered cells for the production of polyunsaturated fatty acids
DK1758469T4 (da) 2004-06-22 2013-11-04 Nutricia Nv Forbedring af barriereintegriteten hos HIV-patienter ved anvendelse af fedtsyrer
RU2007103835A (ru) 2004-07-01 2008-08-10 Шепенс Ай Рисерч (Us) Композиции и способы лечения заболеваний и нарушений состояния глаз
US20070265341A1 (en) 2004-07-01 2007-11-15 The Schepens Eye Research Institute Inc. Compositions and methods for treating eye disorders and conditions
WO2006007463A1 (en) 2004-07-01 2006-01-19 General Mills, Inc. Cultures encapsulated with compound fat breakfast cereals coated with compound fat and methods of preparation
MX2007000304A (es) 2004-07-02 2007-06-15 Baylor Res Inst Metodo de tratamiento de enfermedad de almacenamiento de glucogeno o polisacaridos.
US20060009486A1 (en) 2004-07-07 2006-01-12 Gm Pharmaceuticals Inc. Composition and method for treatment and prevention of coronary artery disease
FR2873295B1 (fr) 2004-07-26 2006-12-01 Expanscience Sa Lab Utilisation d'au moins un triene d'acide gras conjugue pour la preparation d'un medicament destine au traitement de l'inflammation
US20060020031A1 (en) 2004-07-26 2006-01-26 Roger Berlin Compositions containing policosanol and omega-3 fatty acids and their pharmaceutical uses
WO2006017627A2 (en) 2004-08-06 2006-02-16 Barry Sears Dietary compositions comprising docosahexaenoic acid and eicosapentaenoic acid and use thereof for treating insulin resistance
TW200626134A (en) 2004-09-10 2006-08-01 Pronova Biocare A S Treatment of IgA nephropathy with Omega-3 fatty acids
JP2006083136A (ja) 2004-09-17 2006-03-30 Suntory Ltd ストレスに起因する脳機能の低下およびそれに伴う症状あるいは疾患の予防又は改善作用を有する組成物
US7588931B2 (en) * 2004-11-04 2009-09-15 E. I. Du Pont De Nemours And Company High arachidonic acid producing strains of Yarrowia lipolytica
EP1656934A1 (en) 2004-11-12 2006-05-17 Cognis IP Management GmbH Use of physiologically active fatty acids for treating lipodystrophy
WO2006054316A1 (en) 2004-11-16 2006-05-26 Magene Life Sciences Private Limited Method(s) of preparation, stabilization, composition, and administration of gamma-linolenic acid for brain tumors
US7893106B2 (en) 2004-11-19 2011-02-22 Martek Biosciences, Corporation Oxylipins from stearidonic acid and γ-linolenic acid and methods of making and using the same
FR2878747B1 (fr) 2004-12-03 2007-03-30 Pierre Fabre Medicament Sa Utilisation d'acide(s) gras omega-3 pour le traitement de l'hypercholesterolemie causee par un traitement anti-retroviral chez les patients infectes par le vih
US20070191467A1 (en) 2004-12-06 2007-08-16 Reliant Pharmaceutical, Inc. Statin and omega-3 fatty acids for lipid therapy
CN101098690A (zh) 2004-12-06 2008-01-02 瑞莱恩特医药品有限公司 用于血脂治疗的ω-3脂肪酸和脂血异常剂
KR101356335B1 (ko) 2004-12-06 2014-02-06 릴라이언트 파마슈티컬스 인코퍼레이티드 지질 치료를 위한 오메가-3 지방산 및 이상지질혈증 제제
GB2421909A (en) 2004-12-23 2006-07-12 Laxdale Ltd Pharmaceutical compositions comprising EPA and methods of use
GB0428384D0 (en) 2004-12-24 2005-02-02 Sla Pharma Ag Eicosapentaenoic acid
US8324276B2 (en) 2005-01-24 2012-12-04 Pronova Biopharma Norge As Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction
JP4849806B2 (ja) 2005-02-08 2012-01-11 日本水産株式会社 新規な菌体処理方法を用いた高度不飽和脂肪酸の製造方法
ITFI20050024A1 (it) 2005-02-14 2006-08-15 Fernando Cantini Lipidi per l'alimentazione degli animali
WO2006088418A1 (en) 2005-02-18 2006-08-24 Core Competence Sweden Ab A composition comprising a powder containing microencapsulated polyunsaturated long-chain esterified fatty acids distributed in an effervescent base
EP1861087A4 (en) 2005-03-08 2010-02-10 Reliant Pharmaceuticals Inc TREATMENT WITH STATINE AND OMEGA-3-FATTY ACID AS A COMBINATION PRODUCT THEREOF
US20090214475A1 (en) 2005-04-01 2009-08-27 Algaen Corporation Extractability and Bioavailability of the Natural Antioxidant Astaxanthin From a Green Alga, Haematococcus Pluvialis
US20060229366A1 (en) 2005-04-07 2006-10-12 Lifschitz Carlos H Method for preventing or treating respiratory infections in infants
US20060233762A1 (en) 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
EP1714564A1 (en) 2005-04-21 2006-10-25 N.V. Nutricia Method for treatment and prevention of respiratory insufficiency
WO2006116755A2 (en) 2005-04-28 2006-11-02 Trustees Of Tufts College Synergitic effects of docosahexaenoic acid (dha) and carotenoid absorption of cognitive function
ES2264886B1 (es) 2005-05-12 2008-02-01 Proyecto Empresarial Brudy, S.L. Utilizacion de acido docosahexaenoico para el tratamiento de enfermedades tumorales.
US20060270625A1 (en) 2005-05-13 2006-11-30 Eastern Virginia Medical School Nutraceuticals for the treatment of neuropathy
BRPI0613274A2 (pt) 2005-05-23 2009-08-04 Massachusetts Inst Technology composições que contêm pufa e métodos de uso das mesmas
US20060292217A1 (en) 2005-06-03 2006-12-28 Schmidt Robbin D Nutritional supplement and soft gelatin capsule delivery system
WO2006135866A2 (en) 2005-06-10 2006-12-21 Martek Biosciences Corporation Pufa polyketide synthase systems and uses thereof
AU2006263652B2 (en) 2005-06-29 2010-06-17 Hill's Pet Nutrition, Inc. Methods and compositions for the prevention and treatment of inflammatory disease
JP5697293B2 (ja) 2005-06-30 2015-04-08 サントリーホールディングス株式会社 器質的脳障害に起因する高次脳機能の低下に対する改善作用を有する組成物
JP5967855B2 (ja) 2005-06-30 2016-08-10 サントリーホールディングス株式会社 日中活動量の低下および／又はうつ症状の改善作用を有する組成物
EA200800225A1 (ru) 2005-07-01 2008-06-30 Мартек Байосайенсиз Корпорейшн Содержащий полиненасыщенные жирные кислоты маслопродукт и его применения и получение
SG162836A1 (en) 2005-07-08 2010-07-29 Sigma Tau Ind Farmaceuti Use of a combination comprising l-carnitine or alkanoyl l-carnitine, lipid solubl benzoquinone and omega-3-polyunsaturated fatty acid for the preparation of a dietary supplement or medicament for the treatment of corneal diseases
AU2006269405B2 (en) 2005-07-08 2013-01-17 Dsm Ip Assets B.V. Polyunsaturated fatty acids for treatment of dementia and pre-dementia-related conditions
MX2008000915A (es) 2005-07-18 2008-04-04 Reliant Pharmaceuticals Inc Tratamiento con inhibidores de absorcion de colesterol basados en azetidinona y acidos grasos omega-3 y un producto de combinacion de los mismos.
US20070020340A1 (en) 2005-07-25 2007-01-25 David Rubin Fish oil products for reducing cholesterol, low density lipoprotein, and hypertension
ITMI20051560A1 (it) 2005-08-10 2007-02-11 Tiberio Bruzzese Composizione di acidi grassi n-3 con elevata concentrazione di epa e-o dha e contenente acidi grassi n-6
WO2007021735A2 (en) 2005-08-10 2007-02-22 William Llewellyn Use of phospholipid arachidonic acids for increasing muscle mass in humans
US20070042953A1 (en) 2005-08-16 2007-02-22 Bazan Nicolas G Antiepileptogenic complex of albumin with docosahexaenoate
US20070042008A1 (en) 2005-08-18 2007-02-22 Bodybio, Inc. Compositions containing phosphatidylcholine and essential fatty acids
EP1919304B1 (en) 2005-08-26 2011-05-25 Nestec S.A. Compositions and methods for improving functional vascular integrity, cellular survival and reducing apoptosis after an ischemic episode in the brain
JP5222727B2 (ja) 2005-09-06 2013-06-26 オーラメッド・ファーマスーティカルズ・インコーポレイテッド タンパク質を経口投与するための方法及び組成物
WO2007030718A2 (en) 2005-09-09 2007-03-15 Kellogg Company Omega-3 fatty acids encapsulated in zein coatings and food products incorporating the same
US20070134349A1 (en) 2005-09-19 2007-06-14 Duke University Methods of treating hematological malignancies
EP1928552A2 (en) 2005-09-30 2008-06-11 Nestec S.A. Methods and compositions for improving cognitive function
ATE451845T1 (de) 2005-10-05 2010-01-15 Nestec Sa Verwendung einer nährstoffformulierung zur förderung des aufholwachstums
US20070082063A1 (en) 2005-10-11 2007-04-12 Douglas Bibus Risk assessment and correction of membrane damage of the upper GI tract
US20070104779A1 (en) 2005-11-07 2007-05-10 Rongen Roelof M Treatment with omega-3 fatty acids and products thereof
WO2007059439A1 (en) 2005-11-10 2007-05-24 Hill's Pet Nutrition, Inc. Compositions and methods for improving skin health and pelage quality
US20070149617A1 (en) 2005-11-14 2007-06-28 Deckelbaum Richard J Use of an omega-3 lipid-based emulsion following ischemic injury to provide protection and recovery in human organs
WO2007058523A1 (en) 2005-11-17 2007-05-24 N.V. Nutricia Composition with docosapentaenoic acid
US20090069426A1 (en) 2005-11-18 2009-03-12 Hill's Pet Nutrition, Inc. Methods For Reducing The Amount Of A Proinflammatory Substance In Animal Tissue Or Body Fluid
FI20051184A0 (fi) 2005-11-18 2005-11-18 Raisio Yhtymae Oyj Parannettu rasvakoostumus
ES2275435B1 (es) 2005-11-18 2008-06-01 Farmaleis, S.L. "composicion farmaceutica que comprende escualeno y uso de la misma para la preparacion de un medicamento para el tratamiento del cancer.
NO323912B1 (no) 2005-12-01 2007-07-16 Tine Sa Sammensetning, fremgangsmåte til fremstilling derav, og anvendelse derav.
DE102005058369A1 (de) 2005-12-06 2007-06-14 Lts Lohmann Therapie-Systeme Ag Ungesättigte Fettsäuren als Thrombin-Inhibitoren
BRPI0619598A2 (pt) 2005-12-09 2011-10-11 Drugtech Corp composição de emulsão intravenosa de ácido graxo essencial e métodos de administração da mesma
US20070166411A1 (en) 2005-12-16 2007-07-19 Bristol-Myers Squibb Company Nutritional supplement containing long-chain polyunsaturated fatty acids
WO2007075841A1 (en) 2005-12-20 2007-07-05 Cenestra, Llc Omega 3 fatty acid formulations
JP2009523414A (ja) 2005-12-21 2009-06-25 ブルーディ、テクノロジー、ソシエダッド、リミターダ 細胞の酸化的損傷に関連した病変を治療するためのｄｈａ、ｅｐａまたはｄｈａ由来のｅｐａの使用
US20070207975A1 (en) 2006-01-10 2007-09-06 Evanston Northwestern Healthcare Materials and methods for treating and preventing Her-2/neu overexpressing, FAS-elevated cancer cells
US20100112048A1 (en) 2006-01-24 2010-05-06 Majid Fotuhi Dosage Regimen and Medicament For Reducing Risk of Onset or Progression of Dementia by Administration of Specific Vitamins and Nsaid
WO2007089685A2 (en) 2006-01-30 2007-08-09 University Of Georgia Research Foundation Compositions and methods for inducing adipose tissue cell death
EP1983977A4 (en) 2006-01-31 2011-11-30 Martek Biosciences Corp OXYLIPINES FROM STEARIDONIC ACID AND GAMMA-LINOLIC ACID AND METHOD FOR THE PRODUCTION AND USE THEREOF
WO2007100560A2 (en) 2006-02-28 2007-09-07 Bristol-Myers Squibb Company Use of dha and ara in the preparation of a composition for inducing the expression of pulmonary surfactant protein-b
KR20080106415A (ko) 2006-02-28 2008-12-05 브리스톨-마이어스스퀴브컴파니 유전자 발현을 조절하기 위한 조성물의 제조에서 ｄｈａ 및ａｒａ의 용도
US20070218113A1 (en) 2006-02-28 2007-09-20 Miller Debra L Health bars and compositions for improving cardiovascular risk factors
WO2007100562A2 (en) 2006-02-28 2007-09-07 Bristol-Myers Squibb Company Use of dha and ara in the preparation of a composition for reducing triglyceride levels
US20070203235A1 (en) 2006-02-28 2007-08-30 Rosales Francisco J Method for preventing or treating anemia
CA2642969A1 (en) 2006-02-28 2007-09-07 Bristol-Myers Squibb Company Use of dha and ara for increasing lean muscle mass and decreasing adipose tissue in infants
WO2007103160A2 (en) 2006-03-03 2007-09-13 Monsanto Technology Llc Stearidonic acid for improving cardiovascular health
US20070225370A1 (en) 2006-03-21 2007-09-27 Joar Opheim Nutritional Compositions and Methods
US20100086638A1 (en) 2006-04-03 2010-04-08 Kyle David J Feed formulations containing docosahexaenoic acid
JP2009533064A (ja) 2006-04-11 2009-09-17 マーテック バイオサイエンシーズ コーポレーション 長鎖多価不飽和脂肪酸を含む食品製品、およびそれらを調製するための方法
US20090286872A1 (en) 2006-04-12 2009-11-19 John Casey Oral Composition Comprising Dha and Genistein for Enchancing Skin Properties
US20080044487A1 (en) 2006-05-05 2008-02-21 Natural Asa Anti-inflammatory properties of marine lipid compositions
US20070264222A1 (en) 2006-05-10 2007-11-15 Biohealth Advance, Llc Enhanced protection against skin injury in humans
EP1886680A1 (en) 2006-05-23 2008-02-13 Nestec S.A. Maternal supplement
US20070280998A1 (en) 2006-06-02 2007-12-06 Larry Milligan Dairy product
CN101472612B (zh) 2006-06-14 2011-06-08 纽崔西亚公司 包含甘氨酸和乳铁蛋白的抗炎组合物及其应用
CN101472490A (zh) 2006-06-23 2009-07-01 宝洁公司 浓缩型ω-3脂肪酸以及包含它们的混合物
US20070298079A1 (en) 2006-06-26 2007-12-27 Tropicana Products, Inc. Food fortified with omega-3 fatty acids
US20090203780A1 (en) 2006-06-27 2009-08-13 Luisa Gambelli Use of a Polyunsaturated Fatty Acid Compound
AU2007270135B9 (en) 2006-07-05 2013-06-27 Fermentalg Production of ultrapure EPA and polar lipids from largely heterotrophic culture
CA2657748C (en) 2006-07-14 2014-10-21 Nattopharma Asa Pharmaceutical and nutraceutical products comprising vitamin k2
JP2009544701A (ja) 2006-07-21 2009-12-17 リライアント・ファーマシューティカルズ・インコーポレイテッド オメガ３脂肪酸を含む組成物、ならびに末梢動脈障害および間欠性跛行を処置するためのそれらの使用
EP2049098A2 (en) 2006-07-21 2009-04-22 Reliant Pharmaceuticals, Inc. Omega-3 fatty acids for use in treating resistant hypertension
US20080031869A1 (en) 2006-08-02 2008-02-07 Fontaine Juliette S Pain relief composition
WO2008015374A2 (en) 2006-08-04 2008-02-07 Shs International Ltd Protein free formula
FR2904554B1 (fr) 2006-08-04 2010-11-05 Zheng Xu Lipides moleculaires heterogenes cytotropes (lmhc), procede de preparation, et methodes de traitement de patients porteurs de cancers multiples
EP2048970A2 (en) 2006-08-09 2009-04-22 The Iams Company Methods of improving bone health and muscle health
TW200820913A (en) 2006-08-25 2008-05-16 Martek Biosciences Corp Food fortification with polyunsaturated fatty acids
EP1897530A1 (en) 2006-09-08 2008-03-12 DSMIP Assets B.V. Skin care composition
WO2008036353A2 (en) 2006-09-19 2008-03-27 The Trustees Of Columbia University In The City Of New York Omega-3 diglyceride emulsions
WO2008039855A2 (en) 2006-09-26 2008-04-03 Baylor Research Institute Nutrient sensor
US20080085911A1 (en) 2006-10-10 2008-04-10 Reliant Pharmaceuticals, Inc. Statin and omega-3 fatty acids for reduction of apo-b levels
AU2007322291A1 (en) 2006-10-13 2008-05-29 Reliant Pharmaceuticals, Inc. Treatment with antiarrhythmics and omega-3 fatty acids and a combination product thereof
US20080125490A1 (en) 2006-11-03 2008-05-29 My Svensson Treatment and prevention of cardiovascular disease in patients with chronic kidney disease by administering Omega-3 Fatty Acids
US20080118441A1 (en) 2006-11-19 2008-05-22 Washington Joseph A Compositions and methods for the treatment of gastrointestinal conditions
WO2009058799A1 (en) * 2007-11-01 2009-05-07 Wake Forest University School Of Medicine Compositions and methods for prevention and treatment of mammalian diseases
CN101260344B (zh) * 2008-04-22 2010-12-15 天津大学 以微藻油生产二十二碳五烯酸和二十二碳六烯酸混合脂肪酸的方法

Also Published As

Publication number Publication date
CA2761495A1 (en) 2010-11-11
WO2010129565A2 (en) 2010-11-11
JP2012525846A (ja) 2012-10-25
US20130189749A1 (en) 2013-07-25
US8343753B2 (en) 2013-01-01
CN102597255A (zh) 2012-07-18
AU2010246087A1 (en) 2011-11-24
EP2427564A2 (en) 2012-03-14
US20100099765A1 (en) 2010-04-22
WO2010129565A3 (en) 2011-03-31

Similar Documents

Publication Publication Date Title
MX2011011842A (es) Composiciones, metodos y equipos para acidos grasos poliinsaturados a partir de microalgas.
EA201400152A1 (ru) Микроорганизмы, продуцирующие эйкозапентаеновую кислоту, композиции, содержащие жирные кислоты, и способы их получения и применения
MX2016008270A (es) Lipido que comprende acidos grasos poliinsaturados de cadena larga.
MY165048A (en) Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form
NZ601757A (en) Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof
PH12016500216B1 (en) Stable pharmaceutical composition and methods of using same
ZA201502764B (en) Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof
WO2007069078A3 (en) Eukaryotic microorganisms for producing lipids and antioxidants
GEP201606568B (en) Compositions for the treatment of neurologic disorders
MX2015008199A (es) Formulaciones de acido eicosapentaenoico (epa).
RS55859B1 (sr) Oftamološke kompozicije zasnovane na polinezasićenim omega-3 i omega-6 masnim kiselinama
MX2010002404A (es) Composiciones de grasa solida que contiene un acido graso poliinsaturado y usos y produccion de las mismas.
UY34225A (es) Producción de DHA y otros LC-PUFAs (Acidos Grasos Poliinsaturados) en plantas.
MX2016004487A (es) Capsulas blandas de capa entérica que constan de ácidos grasos poli insaturados.
SG10201810439SA (en) Production of long chain polyunsaturated fatty acids in plant cells
NZ595599A (en) Thraustochytrids, fatty acid compositions, and methods of making and uses thereof
UA108850C2 (uk) Екстракт цілісного насіння видів moringa та його застосування у косметичній та/або дерматологічній композиції
TR201819866T4 (tr) Yeni Smb İşlemi
WO2014074552A3 (en) Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy
WO2010108114A3 (en) Polyunsaturated fatty acid synthase nucleic acid molecules and polypeptides, compositions, and methods of making and uses thereof
WO2016027216A3 (en) A synergistic edible oil composition
EP2506848A4 (en) SUBSTANCES TO REDUCE THE IMPACT OF HARD CARDIAL EVENTS CONTAINING AN EXTRACT OF RED FERMENTED RICE AND A MULTIPLE UNSATURATED OMEGA-3 FATTY ACID OR DERIVATIVES THEREOF
MX2010004145A (es) Acidos grasos omega-3 y/o acidos grasos omega-6 y/o esteres de los mismos encapsulados con un recubrimiento.
WO2016040570A3 (en) Dietary emulsion formulations and methods for using the same
MX2015011508A (es) Produccion de acidos grasos omega-3 a partir de la especie pythium.

Legal Events

Date Code Title Description
FG Grant or registration